Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool

International Journal of Cancer

Volumn 141, Issue 2, 2017, Pages 242-253

  Weber, Marianne ^a,b   Yap, Sarsha ^a   Goldsbury, David ^a   Manners, David ^c   Tammemagi, Martin ^d   Marshall, Henry ^e   Brims, Fraser ^f   McWilliams, Annette ^g   Fong, Kwun ^e   Kang, Yoon Jung ^a   Caruana, Michael ^a   Banks, Emily ^h   Canfell, Karen ^a,b,i  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c St John of God Midland Public and Private Hospital   (Australia)

^d BROCK UNIVERSITY   (Canada)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h The Australian National University   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

low dose computed tomography; lung cancer; mass screening; risk prediction model

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIAN; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HIGH RISK POPULATION; HUMAN; INSTRUMENT VALIDATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING; ADVERSE EFFECTS; AUSTRALIA; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; RISK FACTOR; STATISTICAL MODEL;

AGED; AUSTRALIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 85018654135     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30673     Document Type: Article

References (42)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
2. Pinsky PF, Church TR, Izmirlian G, et al. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer 2013;119:3976–83.
3. Australian Institute of Health and Welfare, Cancer Australia, Lung cancer in Australia: An Overview. Cancer series No. 64. Cat. no, CAN 58, 2011.
4. Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409.
5. Lewin G, Morissette K, Dickinson J, et al. Recommendations on screening for lung cancer. CMAJ, 2016;188:425–32.
6. Syrek Jensen T, Chin J, Ashby L, et al. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N), 2015. Available at https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274
7. Wender R, Fontham ET, Barrera E, Jr., et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013;63:107–17.
8. Detterbeck FC, Mazzone PJ, Naidich DP, et al. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e78S–92S.
9. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw 2012;10:240–65.
10. de Koning HJ, Meza R, Plevritis SK, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US preventive services task force. Ann Intern Med 2014;160:311-20.
11. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330–8.
12. Bach PB, Gould MK. When the average applies to no one: personalized decision making about potential benefits of lung cancer screening. Ann Intern Med 2012;157:571–3.
13. Gould MK. Clinical practice. Lung-cancer screening with low-dose computed tomography. N Engl J Med 2014;371:1813–20.
14. Harris RP, Sheridan SL, Lewis CL, et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 2014;174:281–5.
15. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 2012;307:2418–29.
16. Infante M, Cavuto S, Lutman FR, et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 2015;191:1166–75.
17. Wille MM, Dirksen A, Ashraf H, et al. Results of the randomized danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 2016;193:542–51.
18. Vachani A, Jett JR. Screening for lung cancer. Improving outcomes with better patient selection. Am J Respir Crit Care Med 2016;193:478–9.
19. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245–54.
20. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. J Natl Cancer Inst 2011;103:1058–68.
21. Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728–36.
22. Tammemaegi MC, Church TR, Hocking WG, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med 2014;11:e1001764.
23. Li K, Husing A, Sookthai D, et al. Selecting high-risk individuals for lung cancer screening - a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res 2015;8:777–85.
24. Banks E, Redman S, Jorm L, et al. Cohort profile: the 45 and up study. Int J Epidemiol 2008;37:941–7.
25. Mealing NM, Banks E, Jorm LR, et al. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 2010;10:26.
26. Chiew M, Weber MF, Egger S, et al. A cross-sectional exploration of smoking status and social interaction in a large population-based Australian cohort. Soc Sci Med 2012;75:77–86.
27. Weber MF, Banks E, Sitas F. Smoking in migrants in New South Wales, Australia: report on data from over 100 000 participants in The 45 and up study. Drug Alcohol Rev 2011;30:597–605.
28. Banks E, Joshy G, Weber MF, et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med 2015;13:38.
29. Jorm LR, Shepherd LC, Rogers KD, et al. Smoking and use of primary care services: findings from a population-based cohort study linked with administrative claims data. BMC Health Serv Res 2012;12:263.
30. CHeReL. Centre for Health Record Linkage. Available at: http://www.cherel.org.au. Accessed December 12, 2015
31. Kelman CW, Bass AJ, Holman CD. Research use of linked health data–a best practice protocol. Aust N Z J Public Health 2002;26:251–5.
32. Bentley JP, Ford JB, Taylor LK, et al. Investigating linkage rates among probabilistically linked birth and hospitalization records. BMC Med Res Methodol 2012;12:149.
33. Goldsbury D, Weber MF, Yap S, et al. Identifying incident cases of colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study. BMC Med Infor Decis Mak, 2017;17:23.
34. Trajman A, Luiz RR. McNemar chi2 test revisited: comparing sensitivity and specificity of diagnostic examinations. Scand J Clin Lab Invest 2008;68:77–80.
35. Australian Institute of Health and Welfare. 2012. Available at: http://www.aihw.gov.au/copd/prevalence: Accessed June 21, 2016.
36. Young RP, Duan F, Chiles C, et al. Airflow limitation and histology shift in the national lung screening trial. The NLST-ACRIN cohort substdy. Am J Respir Crit Care Med 2015;192:1060–7.
37. Tammemagi MC. Application of risk prediction models to lung cancer screening a review. J Thorac Imaging 2015;30:88–100.
38. Australian Government Department of Health. The Standing Committee on Screening, Position Statement: Lung Cancer Screening using Low-Dose Computed Tomography. Australian Government Department of Health, Canberra, 2015.
39. Berrington de Gonzalez A, Kim KP, et al. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. J Med Screen 2008;15:153–8.
40. Australian Institute of Health and Welfare. National Drug Strategy Household Survey. AIHW, Canberra 2013.
41. Australian Bureau of Statistics. Census of Population and Housing. Commonwealth of Australia, Canberra 2011.
42. Manners D, Hui J, Hunter M, et al. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry. Med J Aust 2016;204:406.